Mayur Jain
About Mayur Jain
Mayur Jain is the Director of Upstream Process Development at Asklepios BioPharmaceutical, Inc., where he has worked since 2021. With over fifteen years of experience in biopharmaceutical organizations, he specializes in manufacturing science, process development, and CMO management.
Current Role at Asklepios BioPharmaceutical
Mayur Jain currently serves as the Director of Upstream Process Development at Asklepios BioPharmaceutical, Inc. (AskBio). He has held this position since 2021 and is responsible for overseeing upstream process development initiatives. His role involves managing various aspects of the biopharmaceutical production process, ensuring efficiency and compliance with industry standards.
Previous Experience at Asklepios BioPharmaceutical
Prior to his current role, Mayur Jain worked at Asklepios BioPharmaceutical, Inc. as the Group Leader for Upstream Process Development from 2020 to 2021. In this capacity, he led a team focused on enhancing upstream processes, contributing to the company's overall operational success in biopharmaceutical manufacturing.
Professional Background in Biopharmaceuticals
Mayur Jain has over fifteen years of experience in the biopharmaceutical sector. His career includes significant roles at various organizations, including Vertex Pharmaceuticals, Humacyte, and Genzyme. His expertise encompasses manufacturing science and technology, process development, and technology transfer, with a strong focus on contract manufacturing organization (CMO) management.
Education and Academic Qualifications
Mayur Jain earned a Master of Science (M.S.) degree in Chemical Engineering from Villanova University, where he studied from 2003 to 2005. His educational background has provided him with a solid foundation in engineering principles, which he has applied throughout his career in the biopharmaceutical industry.
Career Progression and Roles
Throughout his career, Mayur Jain has held various positions that demonstrate his growth in the field. He began as a Process Engineer at ImClone Systems and progressed to roles such as Scientist II at Vertex Pharmaceuticals and Sr. Manager of MSAT/Cell Tissue Procurement at Humacyte. His extensive experience includes facility start-up and expansion for commercial manufacturing.